Finanzdaten der Maxcyte Inc-Aktie (MXCT)
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues | 39.62%10.15 | 7.27 | 9.65 | 7.30 | 6.83 |
| Cost Of Revenue | 0.54%1.68 | 1.68 | 1.57 | 1.61 | 1.60 |
| Gross Profit | 51.32%8.47 | 5.60 | 8.08 | 5.69 | 5.23 |
8.33%14.51 | 15.83 | 14.27 | 16.92 | 19.38 | |
| Research and Development | 32.42%2.87 | 4.25 | 3.86 | 3.34 | 5.32 |
| Depreciation and Amortization | 8.92%0.87 | 0.95 | 1.02 | 1.04 | 1.04 |
| Operating Income/Loss | 40.96%-6.04 | -10.23 | -6.19 | -11.23 | -14.15 |
| Income/Loss From Continuing Operations Before Tax | 46.34%-4.76 | -8.87 | -4.75 | -9.60 | -12.42 |
46.34%-4.76 | -8.87 | -4.75 | -9.60 | -12.42 | |
| Attributable To Parent | 46.34%-4.76 | -8.87 | -4.75 | -9.60 | -12.42 |
| Basic Average Shares | 3.07%103.54 | 106.82 | 106.88 | - | 106.61 |
| Diluted Average Shares | 3.07%103.54 | 106.82 | 106.88 | - | 106.61 |
| Basic Earnings Per Share | 37.50%-0.05 | -0.08 | -0.04 | - | -0.12 |
| Diluted Earnings Per Share | 37.50%-0.05 | -0.08 | -0.04 | - | -0.12 |